We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

87 hedge funds and large institutions have $19.5M invested in Zomedica Corp. in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less capital invested

Capital invested by funds: $20.8M → $19.5M (-$1.35M)

10% less funds holding

Funds holding: 97 → 87 (-10)

11% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 19

50% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 16

Holders
87
Holders Change
-10
Holders Change %
-10.31%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
17
Reduced
19
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$596K
2
VF
Virtu Financial
New York
+$81.4K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$58.3K
4
EDRH
Edmond de Rothschild Holding
Switzerland
+$26.5K
5
TSS
Two Sigma Securities
New York
+$25.5K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$395K
2
GCP
GSA Capital Partners
United Kingdom
-$280K
3
Jane Street
Jane Street
New York
-$243K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$128K
5
Millennium Management
Millennium Management
New York
-$105K
Name Holding Trade Value Shares
Change 		Change in
Stake
GCP
76
GSA Capital Partners
United Kingdom
– -$280K -1,272,480 Closed
ECM
77
ExodusPoint Capital Management
New York
– -$38K -171,703 Closed
WMA
78
West Michigan Advisors
Michigan
– -$28K -126,000 Closed
AQR Capital Management
79
AQR Capital Management
Connecticut
– -$16K -71,096 Closed
Balyasny Asset Management
80
Balyasny Asset Management
Illinois
– -$5K -24,389 Closed
E
81
Ergoteles
New York
– -$5K -24,098 Closed
VPIM
82
Vanguard Personalized Indexing Management
California
– -$5K -21,377 Closed
SFA
83
Sequoia Financial Advisors
Ohio
– -$3K -15,000 Closed
MF
84
Manchester Financial
California
– -$3K -12,300 Closed
Goldman Sachs
85
Goldman Sachs
New York
– -$3K -11,560 Closed
OCPWS
86
One Charles Private Wealth Services
Massachusetts
– -$3K -10,000 Closed
CAPTRUST Financial Advisors
87
CAPTRUST Financial Advisors
North Carolina
– -$2K -8,500 Closed
Barclays
88
Barclays
United Kingdom
– -$1K -5,000 Closed
Bank of America
89
Bank of America
North Carolina
– -$397 -1,500 -58%
APA
90
American Portfolios Advisors
New York
– -$55 -250 Closed
Fidelity Investments
91
Fidelity Investments
Massachusetts
– +$82 +310 +62%
1 2 3
4

ZOM Hedge Fund Activity: Q3 2022 in Review

87 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q3 2022, worth a combined $19.5M — down 6.5% from $20.8M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ZOM and 8 opened new positions — a net loss of 8 holders — while 19 trimmed existing stakes and 17 added.

The largest buyer was Vanguard Group, adding an estimated $596K. The largest seller was Renaissance Technologies, cutting an estimated $395K.

  • 87 institutional investors held Zomedica Corp. (ZOM) as of Q3 2022, down from 97 in Q2 2022.
  • Funds reported $19.5M of Zomedica Corp. stock for Q3 2022, down 6.5% quarter-over-quarter.
  • 8 funds opened new Zomedica Corp. positions in Q3 2022 and 16 closed out, a net change of -8 holders.
  • The largest Zomedica Corp. buyer in Q3 2022 was Vanguard Group, an estimated $596K added.
  • The largest Zomedica Corp. seller in Q3 2022 was Renaissance Technologies, an estimated $395K sold.

Based on aggregated 13F filings for Q3 2022.